{"id":831211,"date":"2025-03-28T14:03:06","date_gmt":"2025-03-28T18:03:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/"},"modified":"2025-03-28T14:03:06","modified_gmt":"2025-03-28T18:03:06","slug":"treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/","title":{"rendered":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PONTE VEDRA, Fla., March  28, 2025  (GLOBE NEWSWIRE) &#8212; Treace Medical Concepts, Inc.\u00a0(\u201cTreace\u201d or the \u201cCompany\u201d) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PluUDBrL5-5N8Taumlx6EoG5pw2iY7O-N5aox9UPSP2GSexTscmU-7459V6j7gghc8OaUroGreoa-94RLBD70iW-5R25EdOeF3THwQnGiXZ-7YPQu6FeV0W4MW-d8hcR7sxWzG9nhhiT3oIFcST9RCfle1MKH3BhFIw5Y5QX4auBPtb73Iv_uXZfDUkuur8IT_18d2cOkIGMTgMSzQvE3oswOxme3E1nezKqPd7l9bF60X_WA4fYXM3t2SldpSU8NJ6_hZEJ9KNYOZ-axCcExxKMr4fPgZcmjOo-g-mIsuKo_69nWIg_2rRaHOMu6--7r9MvQ_YYcabwRo5khOD4vLFfV8dpbEOAWUgo_Zom11GSqj5HMU1TfmUoQShMc-xxXfX4Jrv-Ga61TvZoTBLhpa-vSHm0cCff1yFhNRNoIzcKvmIrRgNf6kb3oY3gycF5e2m_uz-88wuZgqzuPw3kUWM-8l5BeWr5QSY5AJzLcrYB2NkWqJm1pCmTbsGCCxXPiTbYw5CrF7NCsBdlEgYrHQuPI3s7fhgk4_eIKA5MAcC7OSHEABBMA_tyXp1TuW8K\" rel=\"nofollow\" target=\"_blank\">Lapiplasty<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qk9S18TEUBHh2w-qkL14ct--V7pX1vwBeP_cEInV_6oB6V2jET1R80YkjC-wwiWH21VE8T6CP3Ciun2FyZ53r6flTOMOhVb-HI-a7jK3VpokbP8my1nW5sbu7kNjQ-XAym3ZQSJK3FOlmaR9mOe-9aBR_WBfV9RX1OmH6TJPtMzykWuc3mz11PK1On5KlTOatraJlj-UQkOiCoY2oa8fNkc2YdCY8aGc-difrAhwEDkl2xhsRLovyoRf1SCd_12mwZb8dQO5zzkcm3iM3FMk2l6vRC5B66-2anQwf_6R2ciYP1m-f416nkX_KCYEEgiUISkcKs4UjdvIm0dcCh6OXYTxZ62J3AlPSSJPh4wyhhs5ps9D-o8CoYzqqzNG04g7bAzr_x0sLa1j-Z6ZQJ9X-0g3AJ0OcKZx7i0pmDoznEWMM8gWzAR2bxBw95TSA1w2gO2etwy0tR7x0SUY-Dt-0nVP1K0bgjYs-xBytB16ZO7iy_qfn-Z6D7gfKn3bJth9I3eYuukLylKZdXuGKfSOTeJ2lCXLwXE_1YFOAzfXzimbF1k-Us_q9e9AvBJJ3Fcr\" rel=\"nofollow\" target=\"_blank\"><sup>\u00ae<\/sup><\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qyinBWBnl_H5Edxwp4MACgU8H02E2i4GiK59Dfols7P0eTYOYqDM97IUqk-I5HxNeO1t0Dci-FPVejiW_Q-OtQNks_LlMXsATv9SI4varEtM5iKAxaHpicsS4yCbGfX9A35fCHUkIXY8m39pBs3P0pSDGIh_W3MYJiVacSOxT0MGXYsiQPUMX7XtKDfG6qwEo6pAWbSAlz535pS1IHdOTScki3SeX026agDEWNCFNt2wWy0v2SNbAg36xJ-2mSPmIB-vpdYgvnWOI6OKWSgurYOsWzaKqUln6AHAFTSSvv6sHCPchyR5BUE6J0mvy8rRtfBUXzT5Z0pZl1Sk19yB6-E--EmRX9YOYLXsss4j4WKSN9BOIBVidPXuW4w0dFcHXWu5ZyMF74LnBXsJuQAkdrSoLIvm7X2PRSFCzXyVpjVIzkXJ3hnxwMlWnGQCM4B7bxsWxxeQG34EoSbJ8jZ_K3QKwVhzuVOssrboJ45yLz5B7eSHJpQ9cqqHkyxX14KEcv2q4BwdfYrqFo-ePL28MuG7sJifvJrk39eWdjOOWu0_qYZuhyFnd-VVtN2MbH0JTWW3qg5XogbI1q4SvX10ptJoR4NOk77fjgWgl9mV71E=\" rel=\"nofollow\" target=\"_blank\">Adductoplasty<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZxKzegFs1qBbTTLv_CemanIBN-pWEB7yPca_Pb9FnktmSWv_XVF3DeIueb4cjEwEU2s5rYZeYKCJI4ZjpYK2nL3r5drI4t9tOBfVXbc9K7LwW24ds9DB_4qil1ejFLyeQpJhzbnMKguITPyoLR2rN4Oc8P7_vQQSUIfUEs0tOUYj8nK3HvMl7qrsxrI5vVzJJ3RktS2PVDqFqtl088gd0_A-Cg6pE9KjFhRG2uqP0XYcZrfjnzQuXJVqE1jUOIwllbQn09tDCDv9nLcB8-_WBeQjsTj8_-1aUxB3zRRg9R11ft8r5hJEADlL15Dku0i9iXh0TQkehYDNp_CJCRW3LDqNU9cmyHkVuoOGts2Qmcy6B8RsTzafmF3mckCRqrpqW2udMj9H9DRJYxc3_aoj2hw85J3qrXgVn1mwxSOZ4LIABlQGsJGPNxNF5p5ECWeINU4LpKc4xYQeskG3MueB02_ccaSZSl0yMA1ptvpfpjAoKbdDDcWdkXbhTLqQc_HkPw8PAAZzWmEBeny4J4EybW4dsx3Yeth8mXBJwpYpQb9AtVSWALyJRDL07jkmNSzBI_FpM1p99TZzpEu2Yb46Aw==\" rel=\"nofollow\" target=\"_blank\"><sup>\u00ae<\/sup><\/a>\u00a0Procedures, today announced the presentation of updated interim data for the ALIGN3D\u2122 and Mini3D\u2122 Lapiplasty<sup>\u00ae<\/sup> clinical studies, as well as the first presentation of the MTA3D\u2122 Adductoplasty<sup>\u00ae<\/sup> clinical study, at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona.<\/p>\n<p align=\"justify\">\u201cWe are excited to feature our growing body of clinical data to surgeons attending the 2025 ACFAS conference,\u201d stated John T. Treace, CEO, Founder and Board Member of Treace. \u201cThis builds on our commitment to support our flagship Lapiplasty<sup>\u00ae<\/sup> and Adductoplasty<sup>\u00ae<\/sup> procedures with clinical evidence and notably marks the first meeting where all three of our prospective, multicenter studies are presented, including our ALIGN3D\u2122, Mini3D\u2122, and MTA3D\u2122 studies, demonstrating positive clinical outcomes and further differentiating these procedures with surgeons and patients.\u201d<\/p>\n<p>\n        <strong>ALIGN3D\u2122 Lapiplasty<\/strong><br \/>\n        <sup><br \/>\n          <strong>\u00ae<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Clinical Study Presentation<\/strong>\n      <\/p>\n<p align=\"justify\">ALIGN3D\u2122 clinical study results presented by Daniel Hatch, DPM (Foot &amp; Ankle Center of the Rockies, Greeley, CO) on Friday, March 28 as a podium presentation entitled, <em>\u201cFour-Year Analysis of a Five-Year Prospective Multicenter Study Assessing Radiographic Recurrence and Patient Outcomes Following Triplanar Tarsometatarsal Arthrodesis with Early Weightbearing.\u201d <\/em>The featured interim data from the prospective, five-year, multicenter ALIGN3D\u2122 clinical study of the Lapiplasty<sup>\u00ae<\/sup> Procedure included interim analysis of 135 of 173 patients treated with at least four years of follow-up. The data showed:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt\">Early return to protected weight bearing at an average 8.4 days;<\/li>\n<li style=\"margin-bottom:6pt\">Low radiographic recurrence rates of 0.8% using HVA&gt;20\u00b0 and 7.7% using HVA&gt;15\u00b0 at 48 months; and<\/li>\n<li style=\"margin-bottom:6pt\">Continued significant improvement in pain and patient-reported outcome scores (MOxFQ and PROMIS) at 48 months.<\/li>\n<\/ul>\n<p>\n        <strong>Mini3D\u2122 Lapiplasty Mini-Incision\u2122 Clinical Study Presentation<\/strong>\n      <\/p>\n<p align=\"justify\">Mini3D\u2122 clinical study results presented by Jody McAleer, DPM (Jefferson City Medical Group, Jefferson City, MO) on Friday, March 28 as a podium presentation entitled, <em>\u201cProspective Multicenter Study Assessing Radiographic and Patient Outcomes Following an Instrumented Mini-Open Triplanar Tarsometatarsal Arthrodesis with Early Weightbearing.\u201d<\/em>\u00a0The featured results of this prospective, multicenter Mini3D\u2122 clinical study of the Lapiplasty<sup>\u00ae<\/sup> Mini-Incision\u2122 Procedure (median incision length: 3.5cm) included interim analysis of 75 of 105 patients treated with at least one year follow-up. The data showed:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt\">Early return to protected weightbearing at an average 7.9 days;<\/li>\n<li style=\"margin-bottom:6pt\">Low radiographic recurrence rates of 0.0% using HVA&gt;20\u00b0 and 5.5% using HVA&gt;15\u00b0 at 12 months; and<\/li>\n<li style=\"margin-bottom:6pt\">Significant improvements in pain and patient-reported scores (MOxFQ and PROMIS) at 12 months.\u00a0\u00a0<\/li>\n<\/ul>\n<p>\n        <strong>MTA3D\u2122 Adductoplasty<\/strong><br \/>\n        <sup><br \/>\n          <strong>\u00ae<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Clinical Study Presentation<\/strong>\n      <\/p>\n<p align=\"justify\">MTA3D\u2122 clinical study results presented by Paul Dayton, DPM (Foot and Ankle Center of Iowa, Ankeny, IA) on Friday, March 28 as a poster presentation, entitled <em>\u201cInterim 1-Year Analysis of a Prospective Multicenter Study Assessing Radiographic and Patient-Reported Outcomes Following Combined Metatarsus Adductus and Hallux Valgus Correction through 3<\/em><sup><em>rd<\/em><\/sup><em>, 2<\/em><sup><em>nd<\/em><\/sup><em>, and 1<\/em><sup><em>st<\/em><\/sup><em> Tarsometatarsal Arthrodesis with Early Weightbearing.\u201d <\/em> The featured interim data from the prospective, five-year, multicenter MTA3D\u2122 clinical study of the patients undergoing both the Adductoplasty<sup>\u00ae<\/sup> and Lapiplasty<sup>\u00ae<\/sup> procedures included interim analysis of 18 of 38 patients treated with at least one year follow-up. The data showed:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt\">Early return to protected weightbearing at an average 7.5 days;<\/li>\n<li style=\"margin-bottom:6pt\">Clinically significant improvement relative to baseline in radiographic measures of both midfoot (metatarsus adductus) and 3D bunion deformity correction at 12 months; and<\/li>\n<li style=\"margin-bottom:6pt\">Clinically significant reduction in pain and patient-reported scores (MOxFQ and PROMIS) at 12 months.<\/li>\n<\/ul>\n<p align=\"justify\">Additionally, results from a retrospective study on the Adductoplasty<sup>\u00ae<\/sup> Procedure were presented by Jody McAleer, DPM (Jefferson City Medical Group, Jefferson City, MO) on Friday, March 28 as a podium presentation, entitled \u201c<em>Instrumented Correction of Metatarsus Adductus with Hallux Valgus \u2013 A Multicenter Radiographic Assessment.\u201d <\/em>The data from this retrospective clinical study of patients undergoing both the Adductoplasty<sup>\u00ae<\/sup> and Lapiplasty<sup>\u00ae<\/sup> procedures included an analysis of 43 patients treated with a mean follow up of 17.7 months, demonstrating positive clinical results and radiographic correction of both the midfoot (metatarsus adductus) and 3D bunion deformities.<\/p>\n<p align=\"justify\">All ACFAS presentations, which include additional details such as patient demographics, inclusion\/exclusion criteria, and complications reported in the studies, will be available on Treace\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yWA4xClMM9Q5NgXymyi2qSvUYT0VWOdNFUqy_pBFyMg2sN1NUeR5cfPLdGxMIhYBaT3luUg69GbrTujWnL3J20e4AgHYHFf5Tr_wEBdgLZl-f0ePPOJtz58VU-hZ4pBSUdl3T_lSz08f7GevYM-QQ24OHhPorIk4mrwZa_e7SqsU3kjqnNtJxJMqezKwUvnv5wYdZx5I0CWnCqXhxY7Ip1EgloRuRid8GYpClZ1DQgViw90zIB2kgoC4_U2gP6hGuChlGaEIAF5BdylAsXrkRCFLmQ1ZNAIBLBKE8SsU4EtT3l6v0P4Scd0spRtd1X-QViSOA333xU2_-EuIJ68Dj3Fa5ykYe1DbMTWsXlgxh_gC0py5Fm9Lc8vVN9XtnlQlUekr-bePER5hsBZuAhzJGAW-hUA3WzIwALfAsgZ6r-MON-0uCDEUa-xXBq9JNDY_BaBV-JIR6AeuHXOCKWdue8FOHMYQM5WXFuH4HUOVrfY=\" rel=\"nofollow\" target=\"_blank\">www.lapiplasty.com\/surgeons\/journal-publications\/<\/a> following their presentations at ACFAS.\u00a0 More information on Treace\u2019s products can be found at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yWA4xClMM9Q5NgXymyi2qXPJkAoYrclR8uk41wEr9R85peSq-249HusO_FPZrvGsmoN9LLXRwsCL0lYOMRS17vlW4AAirvtIbLlP0Y3CyeRvQbqC6waw3L8aTaPFet_CEhdJ6OW0Z9bJ3LRVJ0h2P9aiXOrdcdLtC5EOKPy8Ugd0Rh0ASw1EeTDwWoCrktiL1dU_Hr2qiS4jVXF1z2g075ouPjIgI_v_277BDVrmXXASo1OTMbZjkSnzCqxG9d6guziCwt0slG5DFyoO7uiE3uYzs5ROvFxKEE6U6XEQCnSaUls7Wz_rSc2BqxDNzniT4ewZJgDF8PEW8DCApNxHp5lW2alQOxXJ8E80YjQHIx9-HZxouzWF6J2IA3tCbFb2tCnOsEDRNDtmIFxzlnIgfA==\" rel=\"nofollow\" target=\"_blank\">www.lapiplasty.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About the ALIGN3D\u2122 Clinical Study<br \/><\/strong>The ALIGN3D\u2122 clinical study is a prospective, multicenter, post-market study designed to evaluate outcomes of the Lapiplasty<sup>\u00ae<\/sup> 3D Bunion Correction<sup>\u00ae<\/sup> procedure in the surgical management of symptomatic hallux valgus. The study will evaluate for consistent and reliable correction of all three dimensions of the bunion deformity with the Lapiplasty<sup>\u00ae<\/sup> Procedure, as well as maintenance of such correction following accelerated return to weight-bearing, initially in a walking boot. The primary effectiveness endpoint is radiographic recurrence of the hallux valgus deformity. Key secondary endpoints include change in three-dimensional radiographic alignment; clinical radiographic healing; time to start of weight-bearing in a boot and in shoes; pain; quality of life; and range of motion of the big toe joint. The study enrolled 173 patients, aged 14 to 58 years, at 7 clinical sites in the United States with 13 participating surgeons. Final patient follow-up for the primary endpoint was completed in the first half of 2023.<\/p>\n<p align=\"justify\">\n        <strong>About the Mini3D\u2122 Clinical Study<br \/><\/strong>The Mini3D\u2122 clinical study is a prospective, multicenter, post-market study designed to evaluate the ability of the Lapiplasty<sup>\u00ae<\/sup> Mini-Incision\u2122 Procedure to consistently and reliably correct all three dimensions of the bunion deformity and maintain the correction following accelerated return to weight-bearing. The study\u2019s primary endpoint is radiographic recurrence of the bunion deformity at 24 months follow up. Secondary endpoints include changes in three-dimensional radiographic alignment; clinical radiographic healing; time to start of weight-bearing in a boot and in shoes; pain; quality of life; range of motion of the big toe joint; scar quality; change in radiographic foot length and width as well as swelling. The study enrolled 105 patients, aged 14 to 58 years, at 9 clinical sites in the United States with 9 participating surgeons.<\/p>\n<p align=\"justify\">\n        <strong>About the MTA3D\u2122 Clinical Study<br \/><\/strong>The MTA3D\u2122 clinical study is a prospective, multicenter, post-market study designed to evaluate the combined Adductoplasty<sup>\u00ae<\/sup> and Lapiplasty<sup>\u00ae<\/sup> Procedures for patients in need of metatarsus adductus and hallux valgus corrective surgery. The study will evaluate for consistent, maintained radiographic correction and patient reported outcome scores following combined Adductoplasty<sup>\u00ae<\/sup> and Lapiplasty<sup>\u00ae<\/sup> procedures. The primary effectiveness endpoint is maintenance of radiographic correction of the hallux valgus and metatarsus adductus deformities. Key secondary endpoints include clinical radiographic healing, time to start weight-bearing in boot and shoes, pain, quality of life, and range of motion of the big toe joint. The study will treat up to 80 patients, aged 14 years and up, at up to 13 clinical sites in the United States. Patients will be followed for 5 years following the procedures.<\/p>\n<p align=\"justify\">\n        <strong>Internet Posting of Information <\/strong>\n      <\/p>\n<p align=\"justify\">Treace routinely posts information that may be important to investors in the \u201cInvestor Relations\u201d section of its website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ab7pXTRL9eWVybGETOZ7HUaz9cyu7LJCN8Ya1Uo-V3_3-gCVFLvpUv8iz3i81USXVg96d8m8oXJV_RHu1wEM36eXnn5kASZyeoAzoruLVKCGEP6di1KVGlfbD_dPBjYqrjhpWbAsiXeWaNSHs4OEnE3yiAo8NpimB0AbxNzsHlZqun1Ada9b-urVCasVVz8tUNI8_ch8DkdrNTfiF9Bqcvj3TSvFLb_phXzMRjgsWEh1EmzkxdBHKnHs5LINExRTJgoWkCmPBIl1Z_9WWynXQ7bImk9j5i7EgwUnYVd2gUkpoI0tyDyUFzzubvw9H2-El_n4eqxtzLZAJoYS1bzjxZ7nn1-s5EtPVfQY-w6vzTy00gvRHX0m9CeXJNUJNux_\" rel=\"nofollow\" target=\"_blank\">www.treace.com<\/a>. The Company encourages investors and potential investors to consult the Treace website regularly for important information about Treace.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Treace Medical Concepts<\/strong>\n      <\/p>\n<p align=\"justify\">Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty<sup>\u00ae<\/sup> 3D Bunion Correction<sup>\u00ae<\/sup> System \u2013 a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of bunion surgeons and address the four classes of bunions, Treace introduced its Adductoplasty<sup>\u00ae<\/sup> Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP\u2122 Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty\u2122 3D Minimally Invasive Bunion Correction System and the Percuplasty\u2122 Percutaneous 3D Bunion Correction System. The Company continues to expand its footprint in the foot and ankle market with the introduction of its SpeedPlate\u2122 Rapid Compression Implants, an innovative fixation platform with broad versatility across Lapiplasty<sup>\u00ae<\/sup>, Adductoplasty<sup>\u00ae<\/sup> and SpeedMTP\u2122 procedures, as well as other common bone fusion procedures of the foot. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ab7pXTRL9eWVybGETOZ7HTlZNv8cEsShfFYUVB_WIjyeOfs4r2zhiTmzhz8_M5BNd5rYftSJ16BkrVQhU11Ggqf87Hw_9viYB8dXJLtDcRjQqpXGJHv0VCZ2jNJoUeEyQ_9DAAFKsSvYshUYmfF0ds4ixsB4ROrnyTMrluwdvLtBMJr9ZmrwGGVNwfUmLMb9XSIMg_U0Cvsu1nYCqFBqH6-lxcBr7aOuSRJoq3vQMvh19CoLg6XaRv2jzSmpe-IvM5jcWysokJCQQAJFt958k8L4NUc2pOEXeu47gukOA3VbRuJtV6WM7WZGOyXYZ7U5ziq4Geucu3xbyqvp6sGx6mPfTpKVgRoZHMI_itgk1GH2nQZDIMXj8BUTFoG5ZQsN\" rel=\"nofollow\" target=\"_blank\">www.treace.com<\/a>.<\/p>\n<p>To learn more about Treace, connect with us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z9urYVn8XPntAVtPqIhI01U859r1-PnlbokGASvzdcSWEdEcHkjO8Biop-i6wJTfppc11u386YgKBXWYBUEXdHsmH61kquveCkTvHm6O6U5jtH4NuNDOFZDLTrkO4snp2uRVtRE6f_PkYwiAF4cZhyFgm8u-O6qy5S4hKJpgfAAmPwIUoRq6gliDzOFiYAC1oIwLHbgLbNISHkjO53LH0cquVHirCABaVMVgGfA2PzqwSrlmK3zzWgY66Ommw15O8RNRPBbttfti-v-gTwbiWRyxCc3nz9AfqIPmlOemkfMHUJrVhOjV5eKRUVTMyeugU8mc_-7z-2L0a5jtVD7SeUSVvpht5OJP4VEmpgNUkME4ejhTrwKKy-w4AokOVzYok5k3WHd4BYoBTwMu6Q9tzAWQfHMpzHqpAsgQnceLH2PbhcjUAsGlf5ub9o6yexD2xNL3M4XT2LycJRqR5NOKMhQCUEWA7CEblXY0FI8RgsSFbe7AQ-n2jtSQAZCHS8nClY5iFHmXm7mqmGZoni-BO1iDyOX_q2m9hGu_oTXd0YT-Mtw6rrr5gvOBGW4HSQ0G\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YG0RNUoV4Y0hZy9Bj5aJlGLgQMQw_3GJFFXeboA1Z7o-diwjQKtPZcVlF-hNLDP451Qtj-rMrMYEL72NFb1yAZw3rVqFgIRK9qOGRrRpgJ0o2Y_5L8vTVJrAHXU1X5DdKGO2hVgZO1K8hry4UTxQj6N0YOYRqIdwlHKGXYdS1rVC-a7Dxx05oBQ8zeFxF480soLP0ppSHk9uM1v3gwS0N7_V9pP5b4zKDVs6S0hnRrqII4yCxgAEDym52B2lJ4J3mwTWfxHVwSCcoh7sIOAi0P0tMw_RQPrJMh66Qzv7sLcxWKp5TsQtuhUzoycehB8nATr-4eykaMSFQHmkYQKmYXZUrfHiIHs1QJ5AIbmuMRIZqHnKaMbrVCKZaJjte5DwnJKaQ4wYXwTbV_t3c8AA1HzBsSbApFPjrCzXMr53QM6c4iK5EsXuVtcppiA73oswPyEy8bvUjn2eVmN4bhnb65DyiLh6oCCZi-iJ5_DBJuehkgfo6t15bA25VaR90e_OZvjnluL-fB3g7yc3sOeJlg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sBIIsGU644kOLyMRLbD7vw4Y005YdK6GnRFkx4EOPyAOl94LFldLfIBHy9RoM30JkRbkfLVPwPBDg80c-CBU3D4vJ79ExtNhpyv-H_jcaugXYyxq4aNnsXP8Npu_bjXtixa0EHJdbliFPrBcYQ5XBl3__SnPtVi1YJhD3fInuuW9pTjmCZhl_S4_JfyVStiKFxQIqEscI2wjjPDDkrS-TeZw5HLBUZJ5iTW7RBnTLWSzuCvFuwqsHv-9UTEJKt28MwNJcRMqw6qwb6KamChWKYl2K_Z_a5M_dRz6wtaTSbwRVwB9-Dy2vmQhLJh0fAr_MEi5h4x0G_1AW4TC62GcDckYuGjtWm4fLklo4mI1_hKWZcZiRd6VF7EgjGMQ55JERNX21Al1sR-am6asdlyB07_0jb8D1qe4aTAq7qxfoUEQI3t-7XIr5a8pEbROf0MFYcwIqSFDh0roCbP4zg1wcHFrxeu_h-lNqTomaFaqbl54dfwsbaXzyvZfxGqQuAFrBRrmOvIYHNHrCqJECTaeI9YOCMNGmT1iPglPU_TQ-dA=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3g4_L2Kt1LKZ_hSoawB4q7K-X2s83nDGwu9deGbMZIRa9ZaFOkFNLorGyapEmKpE-GdQ_-6d1SBKBX-c4RYxZpTlJdBwfKIbqpxpRVMKDwcqhR0843iHrG8_aaF1RC6EhnX4HYDVXtZaXqBmHXu5Xzl-8OJGljKZuYr9k2nK9GgsN_7WERhbS4SSjlFDaNQoEJnepAtFnzjV2cjznoRqWgNUlYSMBL3Q9D0iziTkMwsTH96xv_JlLp24RZaI1ARZZDWH-bT5u-Sx-ZRp8mkx7Kc-hdcbD3EBXq35bgB2m9nSjNW1ypZ2bBx2S56UXMwYssbxWmt5o_ujSxB9YwDI7ZMi3dw6IA3Zbr4iqIyunqwVpa2YUgWXkI_MudemkWzB-akQgIxsZoSfBw4prhF6XuLho1TgP72IwNbryDg8sE8XzMs1BGe0gCqw9d5gjrS-BVBA-3ucoB0CFPU_uiraVKhGK3eGs1a5wv7jPrO1dQ3AaVVdmt0lZUEeNRnOI9k43FiMJ4dmnXppXGKsc_opPr3K6GofJ-5sh4Yx9DKD0y0=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong>:<\/p>\n<p>\n        <strong>Treace Medical Concepts<\/strong><br \/>\n        <br \/>Mark L. Hair<br \/>Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DIav-m9NWtjbDh8j07bLbh3EgB8FJFWQN0otV4es5bUzmkftT-UqgaffXZaETOQzH10WDnx_tU3DQUCcHz-X1ljR4w__8qVug0nY8H1_vhElDPDceF6ANFvo8W7moRxfh7zJ_kNBHnE94OoHD8vfV8gVAaIqjGwpNfBagRS5Ph8gmvcXSH2sG6sLTnQnS2fRaRK0drTD7FiFKjElltha5j-ngabavasJMWYjimrJsGaNUOD7bOWqgpj_Ftfog3KF4Ah6lRBVDXLjGjWdeNUKODXjV7glkB7pyW84Olva2iRzD9tmWw1T6-qYcpzCifeDpoAfxhBc7N90BAsZsLo61HAJ4jAad-NTBL0RwC5HR_Hp9YkLFf246Io4XZZg8vfXsALyMTTuceseYNy2ZUiw-A==\" rel=\"nofollow\" target=\"_blank\">mhair@treace.net<\/a><br \/>(904) 373-5940<\/p>\n<p>\n        <strong>Investors<\/strong>:<br \/><strong>Gilmartin Group<\/strong><br \/>Vivian Cervantes <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bvCDh3lAP58fxE7n92EhwsRec0Rp5MhNOR8bYfNj40f5I6GboOIKgf6_cHbdi6odoB40xl6NU5rmM7k--NKNxqEVVjSW0Qyh7PrGRC-XHl-sfWsWzjLrYaFwcW0n7Rk4qm2blV6yHTsePq72WVd_sbyGcLKy1Nv0pADav_G6kIyPkS-x3i_ecBPuOcGRDlKKs1V3II71I3EZINjq5OUUUnkBDmlwEqhDsB-FXNrRn2LGSd2upWk6z2diju_bIF9o54pEIRf2iE3MlzHBzN3hX5OPpXEt5Xqo8i6w1JS0fvq_a2zxFp6zGO8YFgQzb5zW-lIY8d-gNrV5alf1FXmMMW4I-BuNV0YbixB_C5ZnHhEuKzVfDDuc2On8PtM5nPJi\" rel=\"nofollow\" target=\"_blank\">IR@treace.net<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Yjk5NDlkOTMtMGNiNy00NDhkLWJkZjAtOGEyMGJiMzBmNDU5LTEyMTk1NzgtMjAyNS0wMy0yOC1lbg==\/tiny\/Treace-Medical-Concepts-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) &#8212; Treace Medical Concepts, Inc.\u00a0(\u201cTreace\u201d or the \u201cCompany\u201d) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty\u00ae\u00a0and\u00a0Adductoplasty\u00ae\u00a0Procedures, today announced the presentation of updated interim data for the ALIGN3D\u2122 and Mini3D\u2122 Lapiplasty\u00ae clinical studies, as well as the first presentation of the MTA3D\u2122 Adductoplasty\u00ae clinical study, at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona. \u201cWe are excited to feature our growing body of clinical data to surgeons attending the 2025 ACFAS conference,\u201d stated John T. Treace, CEO, Founder and Board Member of Treace. \u201cThis builds on our commitment to support &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-831211","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) &#8212; Treace Medical Concepts, Inc.\u00a0(\u201cTreace\u201d or the \u201cCompany\u201d) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty\u00ae\u00a0and\u00a0Adductoplasty\u00ae\u00a0Procedures, today announced the presentation of updated interim data for the ALIGN3D\u2122 and Mini3D\u2122 Lapiplasty\u00ae clinical studies, as well as the first presentation of the MTA3D\u2122 Adductoplasty\u00ae clinical study, at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona. \u201cWe are excited to feature our growing body of clinical data to surgeons attending the 2025 ACFAS conference,\u201d stated John T. Treace, CEO, Founder and Board Member of Treace. \u201cThis builds on our commitment to support &hellip; Continue reading &quot;Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-28T18:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference\",\"datePublished\":\"2025-03-28T18:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/\"},\"wordCount\":1450,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/\",\"name\":\"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=\",\"datePublished\":\"2025-03-28T18:03:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/","og_locale":"en_US","og_type":"article","og_title":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference - Market Newsdesk","og_description":"PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) &#8212; Treace Medical Concepts, Inc.\u00a0(\u201cTreace\u201d or the \u201cCompany\u201d) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty\u00ae\u00a0and\u00a0Adductoplasty\u00ae\u00a0Procedures, today announced the presentation of updated interim data for the ALIGN3D\u2122 and Mini3D\u2122 Lapiplasty\u00ae clinical studies, as well as the first presentation of the MTA3D\u2122 Adductoplasty\u00ae clinical study, at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona. \u201cWe are excited to feature our growing body of clinical data to surgeons attending the 2025 ACFAS conference,\u201d stated John T. Treace, CEO, Founder and Board Member of Treace. \u201cThis builds on our commitment to support &hellip; Continue reading \"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-28T18:03:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference","datePublished":"2025-03-28T18:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/"},"wordCount":1450,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/","name":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=","datePublished":"2025-03-28T18:03:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMjg5NCM2ODM5OTE4IzIyMDgwMjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/treace-announces-clinical-study-data-demonstrating-positive-lapiplasty-and-adductoplasty-outcomes-at-the-2025-acfas-annual-scientific-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty\u00ae and Adductoplasty\u00ae Outcomes at the 2025 ACFAS Annual Scientific Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/831211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=831211"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/831211\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=831211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=831211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=831211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}